| Robert Bryan Boyle, APRN | |
|
2802 Orchard Dr, Cedar Falls, IA 50613-5898 | |
| (319) 268-9700 | |
| (319) 268-1934 |
| Full Name | Robert Bryan Boyle |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 2802 Orchard Dr, Cedar Falls, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346557550 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercyone Waterloo Medical Center | Waterloo, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Border Region Mh Mr Community Center | 0648207381 | 18 |
| Bryan Boyle And Associates Pllc | 3870995608 | 2 |
| Covenant Medical Center Inc | 0244148732 | 211 |
News Archive
Today, ASH published new guidelines to help older adults with acute myeloid leukemia (AML) and their health care providers make critical care decisions, including if and how to proceed with cancer treatment and the need for blood transfusions for those in hospice care.
Dr Salman Siddiqui from the University of Leicester's Department of Infection, Immunity and Inflammation, will present his key PhD findings, 'Structure function Relationships in Adult Asthma' in a Doctoral Inaugural Lecture taking place on Wednesday 18 November.
Fifteen percent of Arabs and Chaldeans in the Detroit area say they personally have had a "bad experience" after the Sept. 11 attacks because of their ethnicity, according to preliminary results from a University of Michigan study.
Nuvo Research Inc., a Canadian drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced a new licensing agreement for Oxoferin(TM), its topical wound healing agent, and additional details of the funding assistance to be provided by the Development Bank of Saxony for the development of WF10.
› Verified 2 days ago
| Entity Name | Bexar County Board Of Trustees For Mental Health Mental Retardation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730134586 PECOS PAC ID: 5496652760 Enrollment ID: O20031215000906 |
News Archive
Today, ASH published new guidelines to help older adults with acute myeloid leukemia (AML) and their health care providers make critical care decisions, including if and how to proceed with cancer treatment and the need for blood transfusions for those in hospice care.
Dr Salman Siddiqui from the University of Leicester's Department of Infection, Immunity and Inflammation, will present his key PhD findings, 'Structure function Relationships in Adult Asthma' in a Doctoral Inaugural Lecture taking place on Wednesday 18 November.
Fifteen percent of Arabs and Chaldeans in the Detroit area say they personally have had a "bad experience" after the Sept. 11 attacks because of their ethnicity, according to preliminary results from a University of Michigan study.
Nuvo Research Inc., a Canadian drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced a new licensing agreement for Oxoferin(TM), its topical wound healing agent, and additional details of the funding assistance to be provided by the Development Bank of Saxony for the development of WF10.
› Verified 2 days ago
| Entity Name | Texana Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912954058 PECOS PAC ID: 7618963265 Enrollment ID: O20040421000535 |
News Archive
Today, ASH published new guidelines to help older adults with acute myeloid leukemia (AML) and their health care providers make critical care decisions, including if and how to proceed with cancer treatment and the need for blood transfusions for those in hospice care.
Dr Salman Siddiqui from the University of Leicester's Department of Infection, Immunity and Inflammation, will present his key PhD findings, 'Structure function Relationships in Adult Asthma' in a Doctoral Inaugural Lecture taking place on Wednesday 18 November.
Fifteen percent of Arabs and Chaldeans in the Detroit area say they personally have had a "bad experience" after the Sept. 11 attacks because of their ethnicity, according to preliminary results from a University of Michigan study.
Nuvo Research Inc., a Canadian drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced a new licensing agreement for Oxoferin(TM), its topical wound healing agent, and additional details of the funding assistance to be provided by the Development Bank of Saxony for the development of WF10.
› Verified 2 days ago
| Entity Name | Heart Of Texas Region Mhmr Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639399132 PECOS PAC ID: 9830105105 Enrollment ID: O20060223000214 |
News Archive
Today, ASH published new guidelines to help older adults with acute myeloid leukemia (AML) and their health care providers make critical care decisions, including if and how to proceed with cancer treatment and the need for blood transfusions for those in hospice care.
Dr Salman Siddiqui from the University of Leicester's Department of Infection, Immunity and Inflammation, will present his key PhD findings, 'Structure function Relationships in Adult Asthma' in a Doctoral Inaugural Lecture taking place on Wednesday 18 November.
Fifteen percent of Arabs and Chaldeans in the Detroit area say they personally have had a "bad experience" after the Sept. 11 attacks because of their ethnicity, according to preliminary results from a University of Michigan study.
Nuvo Research Inc., a Canadian drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced a new licensing agreement for Oxoferin(TM), its topical wound healing agent, and additional details of the funding assistance to be provided by the Development Bank of Saxony for the development of WF10.
› Verified 2 days ago
| Entity Name | Border Region Mh Mr Community Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124060173 PECOS PAC ID: 0648207381 Enrollment ID: O20061026000464 |
News Archive
Today, ASH published new guidelines to help older adults with acute myeloid leukemia (AML) and their health care providers make critical care decisions, including if and how to proceed with cancer treatment and the need for blood transfusions for those in hospice care.
Dr Salman Siddiqui from the University of Leicester's Department of Infection, Immunity and Inflammation, will present his key PhD findings, 'Structure function Relationships in Adult Asthma' in a Doctoral Inaugural Lecture taking place on Wednesday 18 November.
Fifteen percent of Arabs and Chaldeans in the Detroit area say they personally have had a "bad experience" after the Sept. 11 attacks because of their ethnicity, according to preliminary results from a University of Michigan study.
Nuvo Research Inc., a Canadian drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced a new licensing agreement for Oxoferin(TM), its topical wound healing agent, and additional details of the funding assistance to be provided by the Development Bank of Saxony for the development of WF10.
› Verified 2 days ago
| Entity Name | Tp-health Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760047526 PECOS PAC ID: 4486089950 Enrollment ID: O20200113000090 |
News Archive
Today, ASH published new guidelines to help older adults with acute myeloid leukemia (AML) and their health care providers make critical care decisions, including if and how to proceed with cancer treatment and the need for blood transfusions for those in hospice care.
Dr Salman Siddiqui from the University of Leicester's Department of Infection, Immunity and Inflammation, will present his key PhD findings, 'Structure function Relationships in Adult Asthma' in a Doctoral Inaugural Lecture taking place on Wednesday 18 November.
Fifteen percent of Arabs and Chaldeans in the Detroit area say they personally have had a "bad experience" after the Sept. 11 attacks because of their ethnicity, according to preliminary results from a University of Michigan study.
Nuvo Research Inc., a Canadian drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced a new licensing agreement for Oxoferin(TM), its topical wound healing agent, and additional details of the funding assistance to be provided by the Development Bank of Saxony for the development of WF10.
› Verified 2 days ago
| Entity Name | Bryan Boyle & Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245535905 PECOS PAC ID: 3870995608 Enrollment ID: O20210715002059 |
News Archive
Today, ASH published new guidelines to help older adults with acute myeloid leukemia (AML) and their health care providers make critical care decisions, including if and how to proceed with cancer treatment and the need for blood transfusions for those in hospice care.
Dr Salman Siddiqui from the University of Leicester's Department of Infection, Immunity and Inflammation, will present his key PhD findings, 'Structure function Relationships in Adult Asthma' in a Doctoral Inaugural Lecture taking place on Wednesday 18 November.
Fifteen percent of Arabs and Chaldeans in the Detroit area say they personally have had a "bad experience" after the Sept. 11 attacks because of their ethnicity, according to preliminary results from a University of Michigan study.
Nuvo Research Inc., a Canadian drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced a new licensing agreement for Oxoferin(TM), its topical wound healing agent, and additional details of the funding assistance to be provided by the Development Bank of Saxony for the development of WF10.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert Bryan Boyle, APRN Po Box 5090, Kingwood, TX 77325-5090 Ph: (713) 481-2808 | Robert Bryan Boyle, APRN 2802 Orchard Dr, Cedar Falls, IA 50613-5898 Ph: (319) 268-9700 |
News Archive
Today, ASH published new guidelines to help older adults with acute myeloid leukemia (AML) and their health care providers make critical care decisions, including if and how to proceed with cancer treatment and the need for blood transfusions for those in hospice care.
Dr Salman Siddiqui from the University of Leicester's Department of Infection, Immunity and Inflammation, will present his key PhD findings, 'Structure function Relationships in Adult Asthma' in a Doctoral Inaugural Lecture taking place on Wednesday 18 November.
Fifteen percent of Arabs and Chaldeans in the Detroit area say they personally have had a "bad experience" after the Sept. 11 attacks because of their ethnicity, according to preliminary results from a University of Michigan study.
Nuvo Research Inc., a Canadian drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced a new licensing agreement for Oxoferin(TM), its topical wound healing agent, and additional details of the funding assistance to be provided by the Development Bank of Saxony for the development of WF10.
› Verified 2 days ago
Jody Zolondek, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 5100 Prairie Pkwy Ste 202, Cedar Falls, IA 50613 Phone: 319-222-2750 Fax: 319-222-2755 | |
Shannon Lee Lindeland, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 5100 Prairie Pkwy Ste 300, Cedar Falls, IA 50613 Phone: 319-277-1990 Fax: 319-277-0572 | |
Jenna Zalk Berendzen, DNP, PMHNP-BC, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 506 W 1st St Ste 2, Cedar Falls, IA 50613 Phone: 319-281-0179 Fax: 319-595-4294 | |
April Lee Barnett, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 5100 Prairie Pkwy, Cedar Falls, IA 50613 Phone: 319-277-1990 | |
Shelby Eldridge, PMHNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1824 W 8th St, Cedar Falls, IA 50613 Phone: 319-277-0992 Fax: 319-277-5768 | |
Kathleen Holden, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 506 W 1st St Ste 2, Cedar Falls, IA 50613 Phone: 319-281-0179 Fax: 319-595-4294 | |
Carolyn Ilene Johnson, NURSE PRACTITIONER Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 516 Division St Ste 110, Cedar Falls, IA 50613 Phone: 319-268-3550 Fax: 319-268-3855 |